Influence of lornoxicam on serum pepsinogen levels.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2149454.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Serum pepsinogen I was determined radioimmunologically in 18 patients suffering from lumbar backache syndromes. These patients were then treated with lornoxicam 4 mg twice daily over a period of 2 weeks. No significant increase in the serum pepsinogen I level was found in 17 (94.4%) of cases. Using the serum pepsinogen I as a parameter for the integrity of the gastric mucosa, this suggests good gastric tolerance of lornoxicam.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Gastric Mucosa
- Pepsinogens
- Piroxicam